Adrenal Tumours: Adrenocortical Functioning Adenomas, Pheochromocytomas, Incidentalomas, and Adrenocortical Cancer

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Advanced Practice in Endocrinology Nursing

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-3-319-99817-6_36
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular imaging and theranostic approaches in pheochromocytoma and paraganglioma

  2018cited by this paper
• Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma

  2017cited by this paper
• PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics.

  2017cited by this paper
• AN INDIVIDUALIZED APPROACH TO THE EVALUATION OF CUSHING SYNDROME.

  2017cited by this paper
• The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.

  2016cited by this paper
• Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.

  2016cited by this paper
• FDG PET/CT Scan and Functional Adrenal Tumors: A Pilot Study for Lateralization

  2016cited by this paper
• Adrenal Imaging: Magnetic Resonance Imaging and Computed Tomography.

  2016cited by this paper
• A genetic and molecular update on adrenocortical causes of Cushing syndrome

  2016cited by this paper
• 68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI

  2016cited by this paper
• Bilateral Adrenal Hyperplasia as a Possible Mechanism for Hyperandrogenism in Women With Polycystic Ovary Syndrome.

  2016cited by this paper
• Genetics of primary hyperaldosteronism.

  2016cited by this paper
• Cushing Disease Presenting as Primary Psychiatric Illness: A Case Report and Literature Review.

  2015cited by this paper
• Primary Aldosteronism and ARMC5 Variants.

  2015cited by this paper
• Constipation: an overlooked, unmanaged symptom of patients with pheochromocytoma and sympathetic paraganglioma.

  2015cited by this paper
• Unilateral Adrenalectomy as a First-Line Treatment of Cushing's Syndrome in Patients With Primary Bilateral Macronodular Adrenal Hyperplasia.

  2015cited by this paper
• Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma

  2015cited by this paper
• Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features

  2014cited by this paper
• Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment.

  2014cited by this paper
• Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity

  2014cited by this paper
• Diagnosis and management of pheochromocytoma.

  2014cited by this paper
• Bone and Mineral Metabolism in Patients with Primary Aldosteronism

  2014cited by this paper
• Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.

  2014cited by this paper
• Phaeochromocytoma crisis

  2014cited by this paper
• Aldosteronoma resolution score predicts long-term resolution of hypertension.

  2014cited by this paper
• Effects of octreotide therapy in progressive head and neck paragangliomas: Case series

  2013cited by this paper
• Mitotane treatment for adrenocortical carcinoma: an overview.

  2012cited by this paper
• Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2012cited by this paper
• An Adrenal Incidentaloma: How Often Is It Detected and What Are the Consequences?

  2012cited by this paper
• Updated and New Perspectives on Diagnosis, Prognosis, and Therapy of Malignant Pheochromocytoma/Paraganglioma

  2012cited by this paper
• Recommendation for standardized surgical management of primary adrenocortical carcinoma.

  2012cited by this paper
• Combination chemotherapy in advanced adrenocortical carcinoma.

  2012cited by this paper
• Current and Future Anatomical and Functional Imaging Approaches to Pheochromocytoma and Paraganglioma

  2012cited by this paper
• A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism

  2011cited by this paper
• AME position statement on adrenal incidentaloma.

  2011cited by this paper
• Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors

  2011cited by this paper
• Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism

  2010cited by this paper
• Clinical, biochemical, and molecular characterization of macronodular adrenocortical hyperplasia of the zona reticularis: a new syndrome.

  2010cited by this paper
• Adrenal imaging.

  2010cited by this paper
• Sporadic solitary aldosterone- and cortisol-co-secreting adenomas: endocrine, histological and genetic findings in a subtype of primary aldosteronism

  2010cited by this paper
• Adrenocortical carcinoma

  2010cited by this paper
• Consequences of adrenal venous sampling in primary hyperaldosteronism and predictors of unilateral adrenal disease.

  2010cited by this paper
• Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors.

  2009cited by this paper
• Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma

  2009cited by this paper
• American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: executive summary of recommendations.

  2009cited by this paper
• False positive test results for pheochromocytoma from 2000 to 2008.

  2009cited by this paper
• [Cushing's syndrome].

  2008cited by this paper
• The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

  2008cited by this paper
• Exploration and management of adrenal incidentalomas. French Society of Endocrinology Consensus.

  2008cited by this paper
• Adrenocortical cancer: pathophysiology and clinical management.

  2007cited by this paper
• Are Somatostatin Analogs Therapeutic Alternatives in the Management of Head and Neck Paragangliomas?

  2005cited by this paper
• Clinical utility of noncontrast computed tomography attenuation value (hounsfield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: Cleveland Clinic experience.

  2005cited by this paper
• MRI of adrenal and extraadrenal pheochromocytoma.

  2005cited by this paper
• Diabetes as a marker of pheochromocytoma in hypertensive patients

  2003cited by this paper
• Virilization in bilateral macronodular adrenal hyperplasia controlled by luteinizing hormone.

  2003cited by this paper
• Management of the Clinically Inapparent Adrenal Mass (Incidentaloma)

  2003cited by this paper
• Biochemical diagnosis of pheochromocytoma: which test is best?

  2002cited by this paper
• Differential diagnosis of pheochromocytomas and paragangliomas.

  2001cited by this paper
• Surgical anatomy and embryology of the adrenal glands.

  2000cited by this paper
• Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.

  2000cited by this paper
• Catecholamine biosynthesis and physiological regulation in neuroendocrine cells.

  2000cited by this paper
• Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland.

  2000cited by this paper
• A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology.

  2000cited by this paper
• Adrenergic Receptors — Evolving Concepts and Clinical Implications

  1996cited by this paper
• Mechanisms of orthostatic hypotension and tachycardia in patients with pheochromocytoma.

  1996cited by this paper
• High expression of cytochrome b5 in adrenocortical adenomas from patients with Cushing's syndrome associated with high secretion of adrenal androgens.

  1993cited by this paper
• A single pediatric center experience with 1025 children with hypertension

  1992cited by this paper
• Control of adrenal androgen secretion.

  1991cited by this paper
• Pheochromocytoma presenting as shock.

  1989cited by this paper
• Adrenergic receptors. Evolving concepts on structure and function.

  1989cited by this paper
• Involvement of alpha-1 and alpha-2 adrenoceptors in the postlaparotomy intestinal motor disturbances in the rat.

  1987cited by this paper
• DEXAMETHASONE SUPPRESSION TESTS: USEFULNESS OF SIMULTANEOUS MEASUREMENT OF PLASMA CORTISOL AND DEXAMETHASONE

  1982cited by this paper
• PHÆOCHROMOCYTOMA

  1954cited by this paper

• Adrenal Incidentaloma Prevalence and Clinical Management- A Retrospective Study

  2024cites this paper